Completed NA INTERVENTIONAL 2-arm NCT00004660

Randomized Study of Sequential Orbital Radiotherapy for Graves' Ophthalmopathy

Phase II Randomized Controlled Study of Sequential Orbital Radiotherapy for Graves' Ophthalmopathy

Sponsor: Mayo Clinic

Interventions Radiotherapy Sham treatment

Updated 6 times since 2017 Last updated: May 25, 2017 Started: Jun 30, 1993 Primary completion: Jan 31, 1998 Completion: Jan 31, 1998

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Graves' Disease, this trial is completed. The trial is conducted by Mayo Clinic and has accumulated 6 data snapshots since 1993. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jul 2017 — Jun 2018 [monthly]

Completed NA

Status: Unknown Status → Completed · Phase: PHASE2 → NA

▶ Show 1 earlier version

Jan 2017 — Jul 2017 [monthly]

Unknown Status PHASE2

First recorded

Jun 1993

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Mayo Clinic
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Data source: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Rochester, United States